Aadrithi Pharmaceuticals Llp - Company Profile

It is a business services limited liability partnership based in Bangalore North, Karnataka, India, established in 2024.
2024 Bangalore North, Karnataka, India Active
Last Updated:
Access Report
About Aadrithi Pharmaceuticals Llp

Aadrithi Pharmaceuticals Llp, a active limited liability partnership, was established on 13 December 2024 in Bangalore North, Karnataka, India. it holds LLPIN: ACK-8240. Registered under ROC Roc Bangalore. It has total obligation of contribution of ₹4.00 M.

Formerly known as Aadrithi Pharmaceuticals Llp. Its leadership includes Ananthu Srinivas (Designated Partner), Vignesh Prasad (Designated Partner), Preety Nandy (Designated Partner). It holds ₹3.00 Cr open charges and no settled loans. It is based at No.65/12, 2Nd A Cross,, Mannorayana Palya, R.T. Nagar Post, Bangalore North, Karnataka, 560032.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    ACK-8240

  • Incorporation Date

    13 December 2024

  • Total Obligation of Contribution

    ₹4.00 M

  • ROC Code

    Roc Bangalore

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 4.00 M
  • Company Age 1 Year 2 Months
  • Open Charges ₹ 3.00 Cr
Company report

Aadrithi Pharmaceuticals Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Aadrithi Pharmaceuticals Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Aadrithi Pharmaceuticals Llp?
Current Designated Partners
Name Designation Appointment Date Status
Ananthu Srinivas Designated Partner 13 Dec 2024 Current
Vignesh Prasad Designated Partner 13 Dec 2024 Current
Preety Nandy Designated Partner 13 Dec 2024 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Aadrithi Pharmaceuticals Llp.
Aadrithi Pharmaceuticals Llp revenue growth over time
Aadrithi Pharmaceuticals Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Aadrithi Pharmaceuticals Llp?

Unlock access to Aadrithi Pharmaceuticals Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹30,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Canara Bank : 3.00 Cr
Latest Charge Details
Date Lender Amount Status
19 Apr 2025 Canara Bank ₹3.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Aadrithi Pharmaceuticals Llp?

Unlock and access historical data on people associated with Aadrithi Pharmaceuticals Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Aadrithi Pharmaceuticals Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aadrithi Pharmaceuticals Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Aadrithi Pharmaceuticals Llp
Recent Activity within the Organization
  • Charges

    The activity A charge with Canara Bank amounted to Rs. 30.00 M with Charge ID 101114492 was registered on 19 Apr 2025. was completed.

  • Annual General Meeting

    The activity Aadrithi Pharmaceuticals Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was completed.

  • Director Appointment

    Ananthu Srinivas was appointed as a Designated Partner was appointed as a Designated Partner on 13 Dec 2024 & has been associated with this company since 1 year 2 months . was recorded as a recent event.

  • Director Appointment

    Progress on Vignesh Prasad was appointed as a Designated Partner was appointed as a Designated Partner on 13 Dec 2024 & has been associated with this company since 1 year 2 months . was documented.

  • Director Appointment

    The activity Preety Nandy was appointed as a Designated Partner was appointed as a Designated Partner on 13 Dec 2024 & has been associated with this company since 1 year 2 months . was completed.

  • LLP Incorporation

    Aadrithi Pharmaceuticals Llp was registered on 13 Dec 2024 with Roc Bangalore & aged 1 year 2 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Aadrithi Pharmaceuticals Llp?

The LLPIN of Aadrithi Pharmaceuticals Llp is ACK-8240.

Where is Aadrithi Pharmaceuticals Llp headquartered?

Aadrithi Pharmaceuticals Llp is headquartered at No.65/12, 2Nd A Cross,, Mannorayana Palya, R.T. Nagar Post, Bangalore North, Karnataka, 560032.

When was Aadrithi Pharmaceuticals Llp incorporated?

Aadrithi Pharmaceuticals Llp was incorporated on 13 December 2024.

Who are the current directors of Aadrithi Pharmaceuticals Llp?

The current directors of Aadrithi Pharmaceuticals Llp are

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available